Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Laboratory Evaluation and Diagnosis of Thalassemia

Norafiza Mohd Yasin

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

Principles of Iron Management in Thalassemia

Nita Radhakrishnan

Treatment of Thalassemia From Transplant to Novel Agents

Nita Radhakrishnan

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

Stefan Eber

Optimal Life-Long Management and Curative Therapies for Transfusion-…

Robert Klaassen

The Evolving Science of Pyruvate Kinase Activation

Joan-Lluis Vives Corrons

Importance of Continuous Monitoring in Thalassemia Patients

Raffaella Origa

iTTP vs. Atypical HUS: Work-Up, Diagnosis, and Initial Treatment

USTMA - The United States Thrombotic Microangiopathy Consortium

S. Agarwal

Molecular Basis of Thalassemia

Norafiza Mohd Yasin

Beyond Transfusion: Current Treatment Options for Managing Thalassem…

Abdulrahman Nasiri

Principles of Transfusion Therapy for Thalassemia

Nita Radhakrishnan

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Thalassemias: Managing Iron Overload and Associated Complications

Soteroula Christou

Overview of the Pathogenesis of Thalassemia

Nita Radhakrishnan